Hot Features
Premium
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Period:
Draw Mode:
| Volume | 131,913 |
|
|||||
| News | - | ||||||
| Day High | 0.6259 | Low High |
|||||
| Day Low | 0.5694 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Kineta Inc | KA | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.0496 | -7.75% | 0.5902 | 15:37:07 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.6259 | 0.5694 | 0.6259 | 0.61 | 0.6398 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 370 | 131,913 | US$ 0.5884313 | US$ 77,622 | - | 0.3339 - 5.39 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 16:17:53 | 30 | US$ 0.6298 | USD |
Kineta Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 19.64M | 10.39M | - | 5.44M | -14.1M | -1.36 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Kineta News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical KA Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.5479 | 0.7399 | 0.4861 | 0.6133138 | 396,182 | 0.0423 | 7.72% |
| 1 Month | 0.5303 | 0.7399 | 0.3339 | 0.5049137 | 903,728 | 0.0599 | 11.30% |
| 3 Months | 2.50 | 2.83 | 0.3339 | 0.6010187 | 398,572 | -1.91 | -76.39% |
| 6 Months | 3.45 | 4.90 | 0.3339 | 0.7597998 | 195,373 | -2.86 | -82.89% |
| 1 Year | 4.03 | 5.39 | 0.3339 | 0.9882746 | 109,635 | -3.44 | -85.35% |
| 3 Years | 8.88 | 9.00 | 0.3339 | 1.41 | 90,770 | -8.29 | -93.35% |
| 5 Years | 8.88 | 9.00 | 0.3339 | 1.41 | 90,770 | -8.29 | -93.35% |
Kineta Description
| Kineta Inc is a clinical-stage biotechnology company with a mission to develop next generation immunotherapies that transform patients' lives. The company's lead asset is KVA12.1, a VISTA blocking immunotherapy. |
